• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by Advent Technologies Holdings Inc.

    7/18/25 4:51:11 PM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous
    Get the next $ADN alert in real time by email
    S-8 1 adventtech_s8.htm S-8

     

    As filed with the Securities and Exchange Commission on July 18, 2025

     

    Registration No. 333-     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

     

    FORM S-8

     

    REGISTRATION STATEMENT

    UNDER

    THE SECURITIES ACT OF 1933

     

     

     

    ADVENT TECHNOLOGIES HOLDINGS, INC.

    (Exact name of Registrant as specified in its charter)

     

    Delaware   83-0982969
    (State or other jurisdiction of
    incorporation or organization)
      (I.R.S. Employer
    Identification No.)

     

    5637 La Ribera St., Suite A,

    Livermore, CA 94550

    (Address of principal executive offices) (Zip code)

     

     

     

    Advent Technologies Holdings, Inc. 2021 Equity Incentive Plan

    (Full title of the plan)

     

     

     

    Gary Herman
    Chief Executive Officer
    5637 La Ribera St., Suite A
    Livermore, CA 94550

    Tel: (925) 455-9400

    (Name, address, including zip code, and telephone number, including area code, of agent for service)

     

    Copies to:

     

    Tom Rosedale, Esq.

    Nutter, McClennen & Fish, LLP

    155 Seaport Boulevard

    Boston, Massachusetts 02110

    (617) 439-2000

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

    Large accelerated filer ☐ Accelerated filer ☐
    Non-accelerated filer ☒ Smaller reporting company ☒
        Emerging growth company ☐

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

     

     

     

     

     

     

    EXPLANATORY NOTE

     

    In this registration statement, Advent Technologies Holdings, Inc. is sometimes referred to as “Registrant,” “we,” “us” or “our.”

     

    The Registrant is filing this Registration Statement on Form S-8 for the purpose of registering an additional 338,776 shares of the Registrant’s common stock, $0.0001 par value per share (the “Common Stock”), issuable pursuant to the Advent Technologies Holdings, Inc. 2021 Equity Incentive Plan (as amended, the “2021 Plan”). The shares being registered pursuant to this Registration Statement are the same class as other securities for which registration statements relating to the 2021 Plan were filed with the Securities and Exchange Commission (the “SEC”) on June 10, 2021 (Commission File No. 333-256986) (the “Prior Registration Statement”).

     

    In accordance with General Instruction E of Form S-8, the contents of the Prior Registration Statement are incorporated herein by reference and made part of this Registration Statement, except as amended hereby.

     

     

     

     

    PART I

    INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

     

    Item 3. Incorporation of Documents by Reference.

     

    The SEC allows us to incorporate by reference the information we file with them, which means that we can disclose important information to you by referring you to those documents. The information incorporated by reference is considered to be part of this registration statement, and later information filed with the SEC will update and supersede this information. We hereby incorporate by reference into this registration statement the following documents previously filed with the SEC:

     

    ● the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the SEC on June 6, 2025;

     

    ● the Registrant’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2025, filed with the SEC on June 30, 2025;

     

    ● the Registrant’s Current Report on Form 8-K filed with the SEC on January 2, 2025, March 11, 2025, April 15, 2025, April 17, 2025, May 27, 2025 and July 3, 2025; and

     

    ● the description of the Registrant’s securities contained on Exhibit 4.4 to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020, filed with the SEC on March 26, 2021, including any amendments or reports filed for the purpose of updating such description.

     

    All documents that the Registrant subsequently files pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act prior to the filing of a post-effective amendment to the registration statement which indicates that all of the securities offered have been sold or which deregisters all such securities then remaining unsold, shall be deemed to be incorporated by reference in this registration statement and to be a part hereof from the date of the filing of such documents, except as to any portion of any future annual or quarterly report to stockholders or document or current report furnished under current Items 2.02 or 7.01 of Form 8-K, and exhibits furnished on such form that relate to such items, that is not deemed filed under such provisions. For the purposes of this registration statement, any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this registration statement.

     

    Under no circumstances will any information filed under current Items 2.02 or 7.01 of Form 8-K, and exhibits furnished on such form that relate to such items, be deemed incorporated herein by reference unless such Form 8-K expressly provides to the contrary.

     

    Item 4. Description of Securities.

     

    Not applicable.

     

    Item 5. Interests of Named Experts and Counsel.

     

    Not applicable.

     

    1

     

     

    Item 6. Indemnification of Directors and Officers.

     

    Section 145 of the General Corporation Law of the State of Delaware provides that a corporation may indemnify any person made a party to an action, suit or proceeding by reason of the fact that he or she was a director, officer, employee or agent of the corporation or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by the person in connection with such action, suit or proceeding if the person acted in good faith and in a manner the person reasonably believed to be in, or not opposed to, the best interests of the corporation and, with respect to any criminal action or proceeding, had no reasonable cause to believe the person’s conduct was unlawful, except that, in the case of an action by or in right of the corporation, no indemnification may generally be made in respect of any claim as to which such person is adjudged to be liable to the corporation.

     

    The Registrant’s Second Amended and Restated Certificate of Incorporation provides that the Registrant’s directors, officers, employees and other agents will be indemnified by the Registrant to the fullest extent authorized by Delaware law, as it now exists or may in the future be amended.

     

    In addition, the Registrant has entered or will enter into indemnification agreements with directors, officers, and some employees containing provisions which are in some respects broader than the specific indemnification provisions contained in the Delaware General Corporation Law. The indemnification agreements will require the Registrant, among other things, to indemnify its directors against certain liabilities that may arise by reason of their status or service as directors and to advance their expenses incurred as a result of any proceeding against them as to which they could be indemnified.

     

    Section 145 of the Delaware General Corporation Law also permits, in general, a Delaware corporation to purchase and maintain insurance on behalf of any person who is or was a director or officer of the corporation, or served another entity in any capacity at the request of the corporation, against liability incurred by such person in such capacity, whether or not the corporation would have the power to indemnify such person against such liability.

     

    The Registrant’s Second Amended and Restated Certificate of Incorporation permits it to secure insurance on behalf of any person who is or was a director, officer, trustee, employee or agent of the Registrant for any liability arising out of his or her actions, regardless of whether the Registrant would have the power or obligation to indemnify such person against such liability under the provisions of the Second Amended and Restated Certificate of Incorporation. The Registrant has purchased a policy of directors’ and officers’ liability insurance that insures its officers and directors against the cost of defense, settlement or payment of a judgment in some circumstances and insures the Registrant against its obligations to indemnify its officers and directors.

     

    Item 7. Exemption from Registration Claimed.

     

    Not applicable.

     

    Item 8. Exhibits.

     

    The following documents are filed as exhibits to this Registration Statement:

     

    2

     

     

                Incorporated by Reference  
    Exhibit Number     Description     Schedule Form     File Number     Exhibit     Filing Date  
    4.1     Second Amended and Restated Certificate of Incorporation of Advent Technologies Holdings, Inc.     8-K     001-38742     3.1     February 9, 2021  
                                     
    4.2     Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of Advent Technologies Holdings, Inc.     8-K     001-38742     3.1     June 20, 2023  
                                     
    4.3     Certificate of Amendment of the Second Amended and Restated Certificate of Incorporation of Advent Technologies Holdings, Inc     8-K     001-38742     3.1     May 16, 2024  
                                     
    4.4     Second Amended and Restated Bylaws of Advent Technologies Holdings, Inc     8-K     001-38742     3.1     September 9, 2022  
                                     
    4.5     Advent Technologies Holdings, Inc. 2021 Equity Incentive Plan     8-K     001-38742     10.12     February 9, 2021  
                                     
    5.1*     Opinion of Nutter McClennan and Fish LLP                          
                                     
    23.1*     Consent of Nutter McClennan and Fish (included in Exhibit 5.1)                          
                                     
    23.2*     Consent of M&K CPAS, PLLC, Independent Registered Public Accounting Firm                          
                                     
    24.1*     Power of Attorney (included on the signature page of this Form S-8).                          
                                     
    107*     Exhibit Fee Table                          

     

     
    * Filed herewith.

     

    3

     

     

    Item 9. Undertakings.

     

    The undersigned Registrant hereby undertakes:

     

    1. To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:

     

    i. To include any prospectus required by Section 10(a)(3) of the Securities Act;

     

    ii. To reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of a prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20 percent change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective Registration Statement; and

     

    iii. To include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement;

     

    provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in periodic reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in the Registration Statement.

     

    2. That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

     

    3. To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

     

    4. The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant’s annual report pursuant to Section 13(a) or 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

     

    5. Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

     

    4

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Livermore, state of California, on this 18th day of July, 2025.

     

      Advent Technologies Holdings, Inc.
       
      By: /s/ Gary Herman
        Name: Gary Herman
        Title: Chief Executive Officer

     

    POWER OF ATTORNEY

     

    KNOW ALL BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Gary Herman and James Coffey, and each of them, as his or her true and lawful attorneys-in-fact and agents, each with the full power of substitution, for him or her and in his or her name, place or stead, in any and all capacities, to sign any and all amendments to this Registration Statement (including post-effective amendments), and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

     

    Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

     

    Name   Position   Date
             
    /s/ Gary Herman   Chief Executive Officer, Interim Chief Financial Officer and Director   July 18, 2025
    Gary Herman  

    (Principal Executive Officer)
    (Principal Financial Officer and Principal Accounting Officer)

       
             
    /s/ Emory De Castro   Chief Technology Officer and Director   July 18, 2025
    Emory De Castro        
             
    /s/ Marc Seelenfreund   Director   July 18, 2025
    Marc Seelenfreund        
             
    /s/ Robert Schwartz   Director   July 18, 2025
    Robert Schwartz        
             
    /s/ Seth Lukash   Director   July 18, 2025
    Seth Lukash        
             
    /s/ Joseph P. Celia   Director   July 18, 2025
    Joseph P. Celia        

     

    5

    Get the next $ADN alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADN

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ADN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Dhaliwal Avtar

    4 - ADVENT TECHNOLOGIES HOLDINGS, INC. (0001744494) (Issuer)

    4/2/25 2:16:33 PM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous

    SEC Form 3 filed by new insider Dhaliwal Avtar

    3 - ADVENT TECHNOLOGIES HOLDINGS, INC. (0001744494) (Issuer)

    4/2/25 2:15:48 PM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous

    SEC Form 3 filed by new insider Lukash Seth M

    3 - ADVENT TECHNOLOGIES HOLDINGS, INC. (0001744494) (Issuer)

    3/11/25 5:56:13 PM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous

    $ADN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Advent Technologies downgraded by Goldman with a new price target

    Goldman downgraded Advent Technologies from Buy to Neutral and set a new price target of $20.00

    5/18/21 6:31:17 AM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous

    Jefferies initiated coverage on Advent Technologies with a new price target

    Jefferies initiated coverage of Advent Technologies with a rating of Buy and set a new price target of $18.00

    3/19/21 8:01:58 AM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous

    Credit Suisse reiterated coverage on Acadian Timber with a new price target

    Credit Suisse reiterated coverage of Acadian Timber with a rating of Underperform and set a new price target of $18.00 from $16.00 previously

    3/17/21 8:43:34 AM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous

    $ADN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Advent Technologies Announces Major Milestone in its Strategic Collaboration with Airbus

    LIVERMORE, Calif., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Advent Technologies Holdings, Inc. (NASDAQ:ADN) an innovation-driven leader in the fuel cell and hydrogen technology sector, is proud to announce a major technological breakthrough in its strategic collaboration with Airbus, aimed at advancing the next generation Ion Pair™ MEA for High-Temperature Proton Exchange Membrane (HT-PEM) fuel cell technology. This achievement marks the successful completion of a critical interim milestone, enabling the project to move toward even more ambitious performance targets. Through a combination of innovative MEA (Membrane Electrode Assembly) reconfiguration and targeted hardware enhancements, Advent h

    9/9/25 8:00:00 AM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous

    Advent Technologies Moves Forward with €34.5 Million RHyno Project Funded by EU Innovation Fund

    ATHENS, Greece, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Advent Technologies Holdings, Inc. (NASDAQ:ADN), an innovation-driven leader in the fuel cell and hydrogen technology space, announce today that its wholly owned Greek subsidiary, Advanced Energy Technologies S.A. has submitted five (5) required deliverables to the European Climate, Infrastructure and Environment Executive Agency (CINEA) -since April 1st 2025 when the RHyno Project officially commenced- and is preparing to submit the first Progress Report in September, covering the initial six months of the €34.5 million RHyno Project. Dr. Nora Gourdoupi, PhD, Advent's Senior Vice President for Business Development stated: "At present, Ad

    9/2/25 8:00:00 AM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous

    Advent Technologies engages Fata Advisory to Support Business Development for Aerospace, Defense, and Commercial Markets

    LIVERMORE, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Advent Technologies Holdings, Inc. (NASDAQ:ADN), an innovation-driven leader in fuel cells and hydrogen technologies, is pleased to announce that it has engaged Fata Advisory, LLC to support the Company's strategic outreach and business development with key U.S. government, commercial, and potential foreign customers in deploying Advent's power generation products for the aerospace, defense, and commercial markets. The firm's founder and principal, Daniel Fata, has more than 30 years of experience working in the Department of Defense, Congress, as well as the U.S. and international aerospace and defense industries including Lockheed Mar

    8/27/25 8:45:00 AM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous

    $ADN
    SEC Filings

    View All

    Advent Technologies Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

    8-K - ADVENT TECHNOLOGIES HOLDINGS, INC. (0001744494) (Filer)

    9/4/25 5:02:06 PM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous

    SEC Form EFFECT filed by Advent Technologies Holdings Inc.

    EFFECT - ADVENT TECHNOLOGIES HOLDINGS, INC. (0001744494) (Filer)

    8/28/25 12:15:22 AM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous

    SEC Form 424B3 filed by Advent Technologies Holdings Inc.

    424B3 - ADVENT TECHNOLOGIES HOLDINGS, INC. (0001744494) (Filer)

    8/27/25 9:23:15 AM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous

    $ADN
    Leadership Updates

    Live Leadership Updates

    View All

    Advent Technologies Announces Management and Board Changes

    LIVERMORE, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Advent Technologies Holdings, Inc. (NASDAQ:ADN) ("Advent "or the "Company"), an innovation-driven leader in the fuel cell and hydrogen technology space, is pleased to announce changes to its board and C-suite by removing Chairman and Chief Executive Officer, Vasilis Gregoriou and Chief Strategy Officer, Chris Kaskavelis. Gary Herman, an experienced turnaround executive has been appointed as Interim CEO. Mr. Herman stated, "The changes were long overdue. Advent has tremendous untapped potential. Its technology is unsurpassed and offers a ubiquitous clean energy solution across multiple industries including aviation, heavy automotive,

    10/30/24 6:10:38 PM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous

    Advent Technologies Receives Nasdaq Notification Regarding Compliance with Listing Requirements and Appoints Three New Directors

    Advent Technologies Holdings, Inc. (NASDAQ:ADN), an innovation-driven leader in the fuel cell and hydrogen technology sectors, today announced that it has received a letter from the Listing Qualifications Department of the Nasdaq Stock Market ("Nasdaq") confirming that the Company has rectified its previous deficiency related to the filing of its annual report on Form 10-K on August 13, 2024. The letter also informed Advent Technologies that it remains noncompliant with Nasdaq Listing Rule 5250(c)(1) due to the delayed filing of its Quarterly Reports on Form 10-Q for the periods ended March 31, 2024 (the "First Quarter 10-Q") and June 30, 2024 (the "Second Quarter 10-Q" and, together with t

    9/4/24 6:01:00 PM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous

    Advent Technologies Announces Appointment of Naiem Hussain as Chief Financial Officer

    Advent Technologies Holdings, Inc. (NASDAQ:ADN), an innovation-driven leader in the fuel cell and hydrogen technology space, announced today the appointment of Naiem Hussain as its new Chief Financial Officer pending the completion of the company's hiring protocols. Formerly serving as Advent's Chief Investment Officer, Mr. Hussain brings extensive expertise in corporate finance, with a focus on IPOs, fundraisings, and mergers and acquisitions within the energy technology and fuel cell industries. Mr. Hussain is replacing Kevin Brackman, who resigned from his position on January 5, 2024. Mr. Hussain's professional journey commenced at ICI plc, where he played a pivotal role in investor re

    1/11/24 6:03:00 PM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous

    $ADN
    Financials

    Live finance-specific insights

    View All

    Advent Technologies Reports Q4 2023 Results

    Advent Technologies Holdings, Inc. (NASDAQ:ADN) ("Advent" or the "Company"), an innovation-driven leader in the fuel cell and hydrogen technology space, announced on Tuesday, August 13, 2024 its consolidated financial results for the three months and year ended December 31, 2023. All amounts are in U.S. dollars unless otherwise noted and have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP"). Q4 2023 Financial Highlights (All comparisons are to Q4 2022, unless otherwise stated) Revenue of $1.5 million and income from grants of $0.8 million, totaling $2.3 million, which represents a decrease of (3.6)% year-over-year. Full year 2023 revenue of $

    8/20/24 7:00:00 AM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous

    Advent Technologies Announces Date for Fourth Quarter and Fiscal 2023 Earnings Call

    Company to Report Q4 2023 Results on August 20, 2024 Advent Technologies Holdings, Inc. (NASDAQ:ADN), an innovation-driven leader in the fuel cell and hydrogen technology sectors, today announced that it will host a conference call on Tuesday, August 20, 2024 at 9:00 AM ET to discuss its fourth quarter and fiscal 2023 financial results. A press release containing these results will be issued before the call. To access the call please dial (800) 715-9871 from the United States, or +1 (646) 307-1963 from outside the U.S. The conference call I.D. number is 9909908. Participants should dial in 5 to 10 minutes before the scheduled time. Participants can also attend the call virtually by vi

    8/14/24 9:28:00 AM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous

    Advent Technologies Reports Q3 2023 Results

    Operational Highlights Signed a term sheet with Airbus to launch a Joint Project for the potential use of HT-PEM fuel cells in aviation. Signed new supply contract with the U.S. Department of Defense of $2.2 million for portable power systems. Received order from a prominent fuel cell integrator in the Asian market with initial value of $1.3 million. Unveiled Advent's range of Serene Power Systems at the 2023 Monaco Yacht Show. Continued discussions with the Greek State to finalize its procedures for state aid funding of Advent's Green HiPo project, following official ratification from the European Commission under the Important Projects of Common European Interest ("IPCEI")

    11/14/23 7:00:00 AM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous

    $ADN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Advent Technologies Holdings Inc. (Amendment)

    SC 13G/A - ADVENT TECHNOLOGIES HOLDINGS, INC. (0001744494) (Subject)

    2/12/24 4:09:47 PM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous

    SEC Form SC 13G/A filed by Advent Technologies Holdings Inc. (Amendment)

    SC 13G/A - ADVENT TECHNOLOGIES HOLDINGS, INC. (0001744494) (Subject)

    1/10/24 2:49:54 PM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous

    SEC Form SC 13G/A filed by Advent Technologies Holdings Inc. (Amendment)

    SC 13G/A - ADVENT TECHNOLOGIES HOLDINGS, INC. (0001744494) (Subject)

    10/3/23 9:43:40 AM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous